Cancer Types
CANCER TYPES
Breast Cancer
Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men
Results of the phase 2 MALE clinical trial comparing 3 treatment regimens in men with hormone-receptor positive breast cancer are reported.
Cancer Diagnoses Increase at Age 65, Decrease Immediately Afterward
The largest increase in cancer diagnosis at age 65 years was in stage I for all breast cancer, colon cancer, prostate cancer, and lung cancer.
Cervical Cancer
Tisotumab Vedotin Under Review for Recurrent or Metastatic Cervical Cancer
Tisotumab vedotin is an investigational antibody-drug conjugate targeted to tissue factor.
Improved Overall Survival With Cemiplimab in Cervical Cancer Trial
The phase 3 trial evaluated the efficacy and safety of cemiplimab in women 18 years of age and older with recurrent or metastatic cervical cancer, including those with either squamous cell carcinoma or adenocarcinoma.
Colorectal Cancer
Outcomes Remain Poor for Colorectal Cancer Patients with Brain Metastases
A retrospective cohort study investigated the incidence of and risk factors for brain metastases in patients with colorectal cancer.
Colorectal Cancer: What Your Patients Need to Know
Although many Americans are at risk of developing colorectal cancer, they may not be aware of their own specific risk factors that they could have for it. What should medical professionals be teaching their patients about on regarding the risks, symptoms, detection, and prevention of colorectal cancer?
Gastrointestinal Cancer
High Body Mass Index Is a Risk Factor for Gallbladder and Biliary Tract Cancer Mortality
Outcomes of Readmissions Following HPB or Gastric Cancer Compared Between Index, Outside Hospitals
Genitourinary Cancer
Obesity Paradox in Renal Cell Carcinoma: Why Do Patients Who Are Obese Have Improved Survival?
Complete TURBT Before Neoadjuvant Chemotherapy Improves MIBC Outcomes
Gynecologic Cancer
Study Reports Improved Outcomes With Olaparib Maintenance in Ovarian Cancer
Most Patients With Breast, Ovarian Cancer Do Not Undergo Genetic Testing
Leukemia
Acute Lymphoblastic Leukemia Patients With Half-Matched Donors See Improved Outcomes
Venetoclax Combinations Do Not Improve Survival, SCT Eligibility in Post-MPN-AML
Liver Cancer
Rurality, Income Impact Stage at Diagnosis, Mortality in Liver Cancer
FDA Denies Accelerated Approval of Keytruda Plus Lenvima for Unresectable HCC
Lung Cancer
Extensive Lymph Node, Node Station Dissection Recommended in Pure-Solid NSCLC
Bone Metastases Lower Overall Survival in mNSCLC Treated With ICIs
Lymphoma
Post-Traumatic Stress Symptoms Seen in Pediatric Hodgkin Lymphoma Survivors
Change in Health Behaviors Affect Quality of Life in Lymphoma Survivors
Melanoma
Trial Designed to Evaluate Efficacy of an SSE Melanoma Screening Campaign
Systemic and Local Therapeutic Approaches Aim to Improve Overall Response in Cutaneous Melanoma
Multiple Myeloma
Multiple Myeloma: What Your Patients Need to Know
Extended Regimen With Carfilzomib, Lenalidomide, and Dexamethasone Is Effective in Newly Diagnosed Multiple Myeloma
Ovarian Cancer
Oral Contraceptives Protect Against Ovarian, Endometrial Cancer
Use of Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Has Doubled
Pancreatic Cancer
Cabozantinib Gets Breakthrough Tx Status for Differentiated Thyroid Cancer
Pegilodecakin Plus FOLFOX Fails to Improve Outcomes in Metastatic PDAC
Prostate Cancer
Effect of Genomic Prostate Score on Active Surveillance Selection in African American Population
Prostate Cancer Survival Rates Vary by Gleason Grade Group 5 Pattern
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Loading... 
Loading...